Answer
Oct 08, 2026 - 09:55 AM
Anafranil SR taken with SNRIs (serotonin-norepinephrine reuptake inhibitors) can increase the risk of serotonin syndrome and QT prolongation. Both conditions can be serious and require monitoring by a healthcare provider.
